Treatment of steroid resistant acute rejection after renal transplantation.
Oh
C K
CK
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Kim
Y S
YS
Kim
M S
MS
Kim
S I
SI
Park
K
K
D000082:Acetaminophen / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D004155:Diphenhydramine / Q000627:therapeutic use; D004351:Drug Resistance; D006084:Graft Rejection / Q000628:therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence
D018712:Analgesics, Non-Narcotic; D000961:Antilymphocyte Serum; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D000082:Acetaminophen; D016572:Cyclosporine; D004155:Diphenhydramine; D006854:Hydrocortisone; D008775:Methylprednisolone